The conference call presentation is available on the pharming website from 14:00 CET on December 16, 2024 A transcript will be made available on the pharming website in the days following the call.

It is said the first cyberattack was committed in 1834 in France, when two people hacked the telegraph system to steal data.

The conference call presentation is available on the pharming.com website from 14:00 CET on December 16, 2024 A transcript will be made available on the pharming.com website in the days following the ...

This is the November / December 2024 edition of Anchovy News. Here you will find articles concerning ICANN, the domain name industry and ...

This Research Topic welcomes Original Research, Reviews, Methodologies, Opinions and Perspectives around: • Design and improvement of bioreactors for plant-based production processes • Molecular ...

“We urge all applicants and stakeholders to be cautious and visit only our official website and not fall prey to spurious or malicious websites engaging in pharming/phishing that resemble the official ...

Pharming is paying $66.1 million to acquire Swedish biotech Abliva and its phase 2-stage med that the Dutch drugmaker believes has blockbuster potential with a type of mitochondrial disease.

Leiden, the Netherlands, December 15, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced a recommended public cash offer to ...

On Monday, Jefferies began coverage on shares of NASDAQ:PHAR, Pharming Group, with a positive outlook, assigning the stock a Buy rating and setting a price target of $14.00. The pharmaceutical ...

6 analysts have expressed a variety of opinions on Pharming PHAR over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of ...

Jefferies initiated coverage of Pharming (PHAR) with a Buy rating and $14 price target The firm believes the market is either underappreciating the Joenja opportunity treating rare disease ...